ATE365172T1 - Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel - Google Patents

Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel

Info

Publication number
ATE365172T1
ATE365172T1 AT99936232T AT99936232T ATE365172T1 AT E365172 T1 ATE365172 T1 AT E365172T1 AT 99936232 T AT99936232 T AT 99936232T AT 99936232 T AT99936232 T AT 99936232T AT E365172 T1 ATE365172 T1 AT E365172T1
Authority
AT
Austria
Prior art keywords
dna
conjugates
compounds
binding compounds
steroid hormones
Prior art date
Application number
AT99936232T
Other languages
English (en)
Inventor
Felix Frey
Sandro Rusconi
Brigitte Frey
Hans-Ueli Wehrli
Original Assignee
Felix Frey
Sandro Rusconi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Felix Frey, Sandro Rusconi filed Critical Felix Frey
Application granted granted Critical
Publication of ATE365172T1 publication Critical patent/ATE365172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99936232T 1998-08-21 1999-08-19 Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel ATE365172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1998/001306 WO2000011019A1 (en) 1998-08-21 1998-08-21 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent

Publications (1)

Publication Number Publication Date
ATE365172T1 true ATE365172T1 (de) 2007-07-15

Family

ID=11004743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936232T ATE365172T1 (de) 1998-08-21 1999-08-19 Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel

Country Status (9)

Country Link
US (1) US6753424B1 (de)
EP (1) EP1105408B1 (de)
JP (1) JP2002523422A (de)
AT (1) ATE365172T1 (de)
AU (2) AU8818398A (de)
CA (1) CA2338342C (de)
DE (1) DE69936348D1 (de)
NZ (1) NZ509294A (de)
WO (2) WO2000011019A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5170934B2 (ja) * 2001-08-16 2013-03-27 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 改良ｄｎａリポフェクションならびに／または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
WO2003070745A2 (en) * 2002-02-20 2003-08-28 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
US20060211004A1 (en) 2005-02-15 2006-09-21 Ilsley Diane D Methods and compositions for determining non-specific cytotoxicity of a transfection agent
EP1844793A1 (de) * 2006-04-13 2007-10-17 D'Angelo, Sante cyklisch amp-bindendes molekuel als vehikel zur gentherapie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
AU6568594A (en) * 1993-04-14 1994-11-08 Boehringer Mannheim Gmbh Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
US5614503A (en) * 1993-11-12 1997-03-25 Aronex Pharmaceuticals, Inc. Amphipathic nucleic acid transporter
US6468981B1 (en) * 1994-07-29 2002-10-22 Emory University Compositions and methods for targeting pharmaceutically active materials to cells containing androgen receptors
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy

Also Published As

Publication number Publication date
CA2338342C (en) 2009-11-24
DE69936348D1 (de) 2007-08-02
JP2002523422A (ja) 2002-07-30
WO2000011018A1 (en) 2000-03-02
EP1105408B1 (de) 2007-06-20
WO2000011019A1 (en) 2000-03-02
EP1105408A1 (de) 2001-06-13
NZ509294A (en) 2003-02-28
AU8818398A (en) 2000-03-14
CA2338342A1 (en) 2000-03-02
AU755710B2 (en) 2002-12-19
US6753424B1 (en) 2004-06-22
AU5146399A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
Zhang et al. Optical control of a CRISPR/Cas9 system for gene editing by using photolabile crRNA
DE59209778D1 (de) Neue konjugate zum einführen von nukleinsäure in höhere eukaryotische zellen
ATE334664T1 (de) Zelldurchlässige peptide zur inhibierung von entzündungsreaktionen und deren verwendung
BR9914643A (pt) Vetores adeno-associados para expressão dofator viii por células alvo
Li et al. Role of deubiquitinating enzymes in DNA double-strand break repair
Dolan et al. Characterization of Escherichia coli SecA protein binding to a site on its mRNA involved in autoregulation.
NO952683D0 (no) Nye colon- eller ileum-spesifikke steroidderivater
NO20033144L (no) Modul¶re transfeksjonssystemer
Stanojevic et al. A highly potent artificial transcription factor
WO1999016791A3 (en) Compounds and methods for regulating cell adhesion
Bruchovsky et al. Androgen receptors: relationship to growth response and to intracellular androgen transport in nine variant lines of the Shionogi mouse mammary carcinoma
Caceres-Cortes et al. Interactions of Deglycosylated Cobalt (III)− Pepleomycin (Green Form) with DNA Based on NMR Structural Studies
George et al. Dynamic access of the glucocorticoid receptor to response elements in chromatin
ATE365172T1 (de) Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel
Slattum et al. Efficient in vitro and in vivo expression of covalently modified plasmid DNA
Sandman et al. A mechanism-based, solution-phase method for screening combinatorial mixtures of potential platinum anticancer drugs
Chae Reconstitution of chromatin. Mode of reassociation of chromosomal proteins
Jing et al. Fully detachable molecular umbrellas as peptide delivery agents
Al‐Dulaymi et al. Tandem mass spectrometric analysis of novel peptide‐modified gemini surfactants used as gene delivery vectors
Villani et al. Effect of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum (II) on the activity of a helicase essential for DNA replication, the herpes simplex virus type-1 origin-binding protein.
Gamboa Varela et al. Simple, High‐Yield Syntheses of DNA Duplexes Containing Interstrand DNA‐DNA Cross‐Links Between an N 4‐Aminocytidine Residue and an Abasic Site
Belitsina et al. Ribosomal Translocation Assayed by the Matrix‐Bound Poly (uridylic acid) Column Technique: Effects of Different Magnesium Concentrations
Ray-Gallet et al. DNA synthesis-dependent and-independent chromatin assembly pathways in Xenopus egg extracts
Liu et al. Tailoring and reversing m6A editing with sequential RNA bioorthogonal chemistry
Furuhata et al. Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties